Assessing adverse event reports of hysteroscopic sterilization device removal using natural language processing-Reference-Cited by-同舟云学术

Assessing adverse event reports of hysteroscopic sterilization device removal using natural language processing

Published:2021-12-21 Issue: Volume: Page:
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiology and Drug

Author:

Mao Jialin¹^ORCID,Sedrakyan Art¹,Sun Tianyi¹,Guiahi Maryam²,Chudnoff Scott³,Kinard Madris⁴,Johnson Stephen B.⁵

Affiliation:

1. Department of Population Health Sciences Weill Cornell Medicine New York New York USA

2. Department of Obstetrics and Gynecology, Division of Family Planning University of Colorado Anschutz Medical Campus Aurora Colorado USA

3. Department of Obstetrics and Gynecology Stamford Hospital Stamford Connecticut USA

4. Device Events York Pennsylvania USA

5. Department of Population Health New York University Langone Health New York New York USA

Funder

Agency for Healthcare Research and Quality

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5402

Reference32 articles.

1. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study

2. Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study

3. U.S. Food and Drug Administration.Essure benefits and risks;2020. Accessed Jun 8 2020.https://www.fda.gov/medical-devices/essure-permanent-birth-control/essure-benefits-and-risks

4. U.S. Food and Drug Administration.FDA activities related to essure;2020. Accessed June 8 2020.https://www.fda.gov/medical-devices/essure-permanent-birth-control/fda-activities-related-essure

5. McGinleyL.Sales of Essure birth control implant to be halted by Bayer; U.S. last to sell controversial device. Accessed June 8 2020.https://www.washingtonpost.com/news/to-your-health/wp/2018/07/20/sales-of-essure-birth-control-implant-halted-by-bayer-u-s-was-last-to-sell-controversial-device/

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Reproducibility of Research Based on the Food and Drug Administration Manufacturer and User Facility Device Experience Data;Journal of Patient Safety;2024-03-13